Dexcom Inc
DXCM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001093557
In the last 90 days, Dexcom Inc insiders filed 0 open-market purchases and 12 sales; 976 institutions reported holding it in 13F filings for Q2 2026, worth $26.0B in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Dexcom Inc changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 920 | 15 | 906 | +1 |
| Shares | 369.6M | 519.8K | 369.3M | +236.9K (+0.1%) |
| Value | $41.8B | $58.3M | $42.9B | +$1.14B (+2.7%) |
15 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (91)
Institutions that held Dexcom Inc at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (90)
Institutions that held Dexcom Inc at the end of Q4 2022 and filed for Q1 2023 without it.
Not filed for Q1 2023 yet (15)
Institutions that held Dexcom Inc at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| HealthCor Management, L.P. | 321,380 | $36.4M |
| Comerica Bank | 132,429 | $14.5M |
| Allstate Investment Management Co | 16,863 | $1.91M |
| Alpha Paradigm Partners, LLC | 13,008 | $1.47M |
| Crosspoint Capital Strategies, LLC | 11,816 | $1.34M |
| Integrity Advisory, LLC | 6,720 | $761.0K |
| Gofen & Glossberg LLC | 6,000 | $679.0K |
| Seeyond | 5,607 | $634.9K |
| Neo Ivy Capital Management | 2,568 | $291.0K |
| Zeke Capital Advisors, LLC | 2,155 | $244.0K |
| CoreCap Advisors, LLC | 308 | $34.9K |
| HealthInvest Partners AB | 299 | $33.9K |
| Cornerstone Planning Group LLC | 130 | $13.8K |
| Heritage Wealth Management, LLC | 80 | $9.06K |
| Boenning & Scattergood, Inc. | 470 | – |